Skip to main content
FinSpry Logo
FinSpry
GANX logo
GANX
(NASDAQ)
Gain Therapeutics, Inc.
$1.83-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Gain Therapeutics (GANX) Stock Price & Financial Analysis

Gain Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.77 - $1.85
52-Week High$4.34
52-Week Low$1.53
Open$1.80
Volume291.54K
Average Volume (3M)442.65K
Market Cap76.01M
Shares Outstanding42.23M
Price to Book (P/B)5.43
EV/EBITDA-3.06
50-Day MA$1.85
200-Day MA$2.16
52-Week Change4.57%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Gain Therapeutics

What is the current stock price for GANX?

As of the latest trading session, GANX stock trades at $1.83. The 52-week range is $1.53–$4.34, with a day range of $1.77–$1.85.

What is the P/E ratio for GANX?

The P/E ratio (Price-to-Earnings) for GANX is shown in the Key Statistics section. This valuation metric helps compare Gain Therapeutics, Inc. to industry peers.

Does GANX pay dividends?

Gain Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GANX?

Based on 4 analysts, the consensus for GANX is Buy.

What is the market cap of GANX?

Gain Therapeutics's market capitalization is $77.3M, classifying it as a micro-cap company. Gain Therapeutics operates in the Healthcare sector within the Biotechnology industry.